1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015" provides data on the Pediculosis (Head Lice Infestation) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediculosis (Head Lice Infestation). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pediculosis (Head Lice Infestation). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pediculosis (Head Lice Infestation) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Pediculosis (Head Lice Infestation) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Hatchtech Pty, Ltd 32
Clinical Trial Overview of Hatchtech Pty, Ltd 32
ParaPRO LLC 33
Clinical Trial Overview of ParaPRO LLC 33
Stada Arzneimittel AG 34
Clinical Trial Overview of Stada Arzneimittel AG 34
Sun Pharmaceutical Industries Limited 35
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Summers Laboratories Incorporated 37
Clinical Trial Overview of Summers Laboratories Incorporated 37
Oystershell NV 38
Clinical Trial Overview of Oystershell NV 38
Lybar, a.s. 39
Clinical Trial Overview of Lybar, a.s. 39
EctoPharma Ltd. 40
Clinical Trial Overview of EctoPharma Ltd. 40
Altman Biomedical Consulting Pty. Ltd 41
Clinical Trial Overview of Altman Biomedical Consulting Pty. Ltd 41
Clinical Trial Overview of Top Institutes / Government 42
Mandacaru Foundation 42
Clinical Trial Overview of Mandacaru Foundation 42
Shiraz University of Medical Sciences 43
Clinical Trial Overview of Shiraz University of Medical Sciences 43
Assistance Publique Hopitaux De Marseille 44
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 44
Australian National University 45
Clinical Trial Overview of Australian National University 45
Centers for Disease Control and Prevention 46
Clinical Trial Overview of Centers for Disease Control and Prevention 46
Hackensack University Medical Center 47
Clinical Trial Overview of Hackensack University Medical Center 47
Royal Free London NHS Foundation Trust 48
Clinical Trial Overview of Royal Free London NHS Foundation Trust 48
South Florida Family Health And Research Centers 49
Clinical Trial Overview of South Florida Family Health And Research Centers 49
Tokyo University of Science 50
Clinical Trial Overview of Tokyo University of Science 50
Five Key Clinical Profiles 51
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

List of Tables
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Pediculosis (Head Lice Infestation) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Pediculosis (Head Lice Infestation) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Pediculosis (Head Lice Infestation) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Pediculosis (Head Lice Infestation) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Pediculosis (Head Lice Infestation) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Pediculosis (Head Lice Infestation) Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Pediculosis (Head Lice Infestation) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hatchtech Pty, Ltd, 2015* 32
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by ParaPRO LLC, 2015* 33
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stada Arzneimittel AG, 2015* 34
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2015* 35
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 36
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Summers Laboratories Incorporated, 2015* 37
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oystershell NV, 2015* 38
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lybar, a.s., 2015* 39
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by EctoPharma Ltd., 2015* 40
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Altman Biomedical Consulting Pty. Ltd, 2015* 41
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mandacaru Foundation, 2015* 42
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 43
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015* 44
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Australian National University, 2015* 45
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2015* 46
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hackensack University Medical Center, 2015* 47
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Free London NHS Foundation Trust, 2015* 48
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by South Florida Family Health And Research Centers, 2015* 49
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo University of Science, 2015* 50

List of Figures
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Pediculosis (Head Lice Infestation) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Pediculosis (Head Lice Infestation) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Pediculosis (Head Lice Infestation) to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Pediculosis (Head Lice Infestation) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Pediculosis (Head Lice Infestation) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Pediculosis (Head Lice Infestation) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Pediculosis (Head Lice Infestation) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Pediculosis (Head Lice Infestation) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.